Post by
subaru1i on Mar 20, 2024 9:51pm
DEA cannabis rescheduling model from 3 to 1 is done!
I missed it until now because it happened over a long period of time. The DEA model for rescheduling cannabis from a schedule 1 to schedule 3 is EXTREMELY simple and there is an example of it already.
The simple part is this: DOJ/DEA has rescheduled cannabis from a schedule 1 to schedule 3 substance and can be used by FDA registered pharmaceutical companies for pharmaceutical applications.
The example is this: Medipharm Labs received FDA approval as a pharmaceutical company for cannabinoid active pharmaceutical ingredients. The DEA approved the import into the U.S. from Medipharm Labs in Canada for pharmaceutical applications. In our case it was the NIH funding a clinical trial study, for example, the Libby Study at the Keck School of Medicine at University of Southern California.
Medipharms is the example of the model for rescheduling cannabis from 1 to 3 by the DEA because LABS is a pharmaceutical company registed with the FDA and so IS their traditional global pharmaceutical partner.
Have a nice evening everyone and I do hope no one is caught with their pants and facing a +$10 gap in price when the news hits of LABS and their global pharma partner.
Comment by
subaru1i on Mar 20, 2024 9:53pm
Correction: Got so excited title should read "from 1 to 3 is done!"
Comment by
QContinuum1 on Mar 21, 2024 7:17am
So you're predicting a schedule change? How clairvoyant....lol....must be all of that universal background radiation that your missus emanates....
Comment by
subaru1 on Mar 21, 2024 10:30am
Desinformation again, he is playing with the emotion of people, poor guy..
Comment by
Starkicker on Mar 21, 2024 11:26am
He's desperate His space dust missus let him buy a $30k Italian trap gun thinking LABS was about to go to $20/share and now he can't afford it.